Department of Clinical Psychology and Psychological Therapies, Norwich Medical School, Faculty of Medicine and Health Sciences, University of East Anglia, Norwich, United Kingdom.
Department of Clinical Psychology and Psychological Therapies, Norwich Medical School, Faculty of Medicine and Health Sciences, University of East Anglia, Norwich, United Kingdom; School of Health Sciences, Faculty of Medicine and Health Sciences, University of East Anglia, Norwich, United Kingdom; Norfolk and Norwich University Hospital, Norwich, United Kingdom; The Euan MacDonald Centre for Motor Neurone Disease, University of Edinburgh, Edinburgh, United Kingdom; Alzheimer Scotland Dementia Research Centre, University of Edinburgh, Edinburgh, United Kingdom; Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, United Kingdom.
J Neurol Sci. 2022 Mar 15;434:120103. doi: 10.1016/j.jns.2021.120103. Epub 2021 Dec 22.
Apathy, a disorder of motivation observed in up to 40% of stroke survivors, is negatively associated with stroke rehabilitation outcomes. Different apathy subtypes have been identified in other conditions, but there is currently no validated multidimensional measure of post-stroke apathy (PSAp). The Dimensional Apathy Scale (DAS) assesses apathy across three subtypes: Executive, Emotional and Initiation apathy. We aimed to determine if the DAS is a reliable and valid tool to detect and characterise apathy in stroke. Fifty-three stroke survivors, (45.3% males, median age 54), and 71 people without stroke (26.8% males, median age 45) completed measures of apathy (DAS, Apathy Evaluation Scale, AES), depression (Patient Hospital Questionnaire, PHQ-9) and anxiety (Generalised Anxiety Disorder scale, GAD-7) as part of an online survey. The DAS showed high internal consistency and convergent validity with the current gold standard unidimensional assessment for apathy (AES) and divergent validity with depression (PHQ-9) and anxiety (GAD-7). Stroke survivors scored significantly higher on the total score of the DAS and all subscales, compared with controls. There were however no significant differences on depression and anxiety scores between the two groups. Our results suggest the DAS is a reliable and valid screening tool to detect and characterise PSAp.
淡漠,一种在高达 40%的中风幸存者中观察到的动机障碍,与中风康复结果呈负相关。在其他情况下已经确定了不同的淡漠亚型,但目前还没有经过验证的用于评估中风后淡漠(PSAp)的多维测量工具。维度淡漠量表(DAS)评估三种亚型的淡漠:执行性淡漠、情感性淡漠和启动性淡漠。我们旨在确定 DAS 是否是一种可靠且有效的工具,用于检测和描述中风患者的淡漠。53 名中风幸存者(45.3%为男性,中位年龄 54 岁)和 71 名非中风者(26.8%为男性,中位年龄 45 岁)完成了淡漠量表(DAS、淡漠评估量表、AES)、抑郁(患者医院问卷、PHQ-9)和焦虑(广泛性焦虑障碍量表、GAD-7)的评估,作为在线调查的一部分。DAS 表现出与当前评估淡漠的金标准(AES)高度的内部一致性和收敛有效性,以及与抑郁(PHQ-9)和焦虑(GAD-7)的发散有效性。与对照组相比,中风幸存者在 DAS 总分和所有分量表上的得分都明显更高。然而,两组在抑郁和焦虑评分上没有显著差异。我们的结果表明,DAS 是一种可靠且有效的筛查工具,用于检测和描述 PSAp。